Treatments · Cornea · Fuchs Endothelial Dystrophy · Updated May 2026
Private DSO (Descemet Stripping Only) for Fuchs dystrophy, UK 2026
DSO — Descemet Stripping Only, also called DWEK (Descemet Stripping Without Endothelial Keratoplasty) — is a minimally invasive operation for selected patients with early to moderate Fuchs endothelial dystrophy. Instead of replacing the back layer of your cornea with donor tissue (as in DMEK or DSAEK), the surgeon simply peels away a small disc of diseased Descemet membrane and endothelium from the centre of your cornea, leaving the healthy peripheral cells to migrate inwards and re-coat the area over the following weeks and months. No donor tissue means no rejection risk and full preservation of your future treatment options. At CQC-registered UK centres in 2026, self-pay pricing is typically £4,500-£7,500 per eye as a standalone procedure, or bundled at around £6,500-£9,500 when combined with cataract surgery and an intraocular lens.
- Typical cost: £4,500-£7,500 per eye (DSO alone), or £6,500-£9,500 with combined cataract surgery (UK 2026).
- Best for: mild-to-moderate Fuchs with central guttae and a healthy peripheral endothelium.
- No donor tissue: zero graft-rejection risk; future DMEK/DSAEK remains possible.
- Adjunct drops: ROCK inhibitors (netarsudil/ripasudil) may accelerate corneal clearance.
- Procedure: day case, topical anaesthesia, around 15-25 minutes per eye.
Private consultant corneal assessment: 0800 852 7782. Same-week appointments at CQC-registered UK clinics; transparent UK 2026 self-pay and insurer-billed pathways.
Fast answer: what is DSO and what does it cost?
DSO — Descemet Stripping Only — is a transplant-free operation for Fuchs endothelial dystrophy. The surgeon removes a small (typically 4 mm) disc of diseased Descemet membrane and endothelium from the centre of your cornea and lets your own peripheral endothelial cells migrate in to repopulate the cleared zone. You keep all of your own corneal tissue, no donor cornea is used, and there is no graft-rejection risk — but the procedure only suits patients who still have enough healthy endothelium in the periphery to do the repopulating work.
Typical cost per eye
£4,500-£7,500 standalone (UK 2026).
Combined with cataract
£6,500-£9,500 (DSO + phaco + monofocal IOL).
Donor tissue
None — no rejection risk.
Time to clear
Usually 4-12 weeks (sometimes longer).
Honest one-liner: DSO is the right operation when you want to treat Fuchs without committing to a donor graft — but it only works in eyes whose peripheral endothelium can still do the repair, and in around 1 in 5 it fails to clear and a DMEK is still needed.
What is Descemet Stripping Only (DSO) for Fuchs dystrophy?
The back surface of your cornea is lined by a single layer of endothelial cells sitting on Descemet membrane. Their job is to pump fluid out of the cornea to keep it clear. In Fuchs endothelial dystrophy, these cells dwindle in number and accumulate microscopic warts called guttae, mostly centrally. Once the cell count falls below a critical level, fluid builds up, the cornea swells, and vision becomes hazy, glary, and worst on waking.
For decades, the only treatment for visually significant Fuchs was a corneal transplant. Modern lamellar techniques — DSAEK and especially DMEK — replace only the diseased back layer with donor tissue, with excellent results. DSO takes that idea one step further: in a carefully selected patient, the surgeon removes the diseased central zone without replacing it with donor tissue at all, relying on the eye's own peripheral endothelial cells to migrate centrally over weeks to months and recoat the back of the cornea.
The technique was pioneered after surgeons noticed that some Fuchs eyes cleared spontaneously when small Descemet detachments occurred during cataract surgery, and that allowing the peripheral cells to repopulate produced a clear cornea without any graft. DSO is now an established, if specialist, option for early-to-moderate Fuchs, particularly in younger patients keen to avoid donor tissue, and is frequently combined with cataract surgery so that visual rehabilitation can be addressed at the same time.
UK 2026 private DSO cost per eye
All-in self-pay fees at CQC-registered UK clinics typically include consultant fees, anaesthetist (if used), theatre and hospital costs, the post-operative drop regime, and a defined package of follow-up visits up to 3-6 months. Always ask for a fully itemised quote covering both eyes and the cost of rescue DMEK should DSO fail.
What is included in a private DSO package?
Specialist cornea consultation
Best-corrected acuity, slit-lamp grading of guttae and oedema, specular microscopy for endothelial cell density, pachymetry, and Scheimpflug or anterior-segment OCT.
Patient selection workup
Confirmation of healthy peripheral endothelium, absence of advanced stromal scarring, and discussion of combined cataract surgery if a cataract is present.
Theatre and surgeon fees
Day-case CQC-registered ophthalmic theatre, consultant cornea surgeon, theatre team and anaesthetist if used.
Descemet stripping
Controlled 3.5-4.5 mm central Descemetorhexis, sometimes a small descemetectomy peel, leaving stroma and peripheral endothelium intact.
Adjunct ROCK inhibitor drops
A course of netarsudil or ripasudil, used off-licence in selected cases to accelerate endothelial migration and corneal clearance.
Structured follow-up
Reviews at day 1, 1 week, 1 month, 3 months and 6 months, with repeat imaging to track corneal thickness and clearance.
What does the evidence say about DSO?
DSO has accumulated more than a decade of peer-reviewed evidence since the early descriptions by Moshirfar, Garcerant and others, with larger prospective series subsequently reported by Borkar, Colby and the cornea groups at Massachusetts Eye and Ear, Devers Eye Institute, and several European centres. Across these cohorts, the headline findings are consistent: in well-selected eyes with peripheral endothelial cell density above roughly 1,000 cells/mm² and a central stripping diameter of around 4 mm, around 75-85% of corneas clear without further surgery, with median time to clearance in the order of 4-12 weeks and final best-corrected vision typically matching, or in some series exceeding, what is achieved with DMEK.
The addition of a topical ROCK inhibitor (rho-kinase inhibitor) such as netarsudil 0.02% or ripasudil 0.4% has been shown in multiple series to shorten time to clearance and improve the proportion of eyes that clear, by promoting endothelial proliferation and centripetal migration. Failure of clearance, where it occurs, is generally manageable with subsequent DMEK without compromising the final result.
Patient-reported outcomes have been favourable, particularly in younger patients, who value the absence of donor tissue, lower long-term steroid burden compared with a graft, and the preservation of future surgical options. The technique remains a specialist procedure: outcomes depend heavily on case selection (good peripheral endothelium, no advanced stromal involvement) and on the surgeon's experience with the descemetorhexis manoeuvre.
DSO vs DMEK, DSAEK and watchful waiting
See our pages on ultra-thin DSAEK and DMEK transplant cost for detailed comparators, and our treatments index for the broader corneal surgery menu.
Are you a candidate for DSO?
Good candidates
- Confirmed Fuchs endothelial dystrophy with central guttae.
- Healthy peripheral endothelial cell density (broadly >1,000 cells/mm²).
- Mild-to-moderate corneal oedema; pachymetry typically < 650 μm.
- Younger patient, motivated to avoid donor tissue.
- Coexisting cataract suitable for combined cataract surgery.
Better suited to DMEK/DSAEK
- Advanced Fuchs with bullous keratopathy or stromal scarring.
- Low peripheral endothelial cell density.
- Previous corneal graft failure.
- Need for a guaranteed, faster visual recovery.
- Limited ability to attend prolonged follow-up.
Candidacy is decided after a detailed cornea consultation with imaging. Many patients will benefit from a free initial online review followed by an in-person assessment.
NHS vs private DSO in the UK
NHS corneal services do offer DSO at a handful of tertiary cornea units, but it remains a specialist option and access is uneven across the country. Most NHS Fuchs pathways still default to DMEK or DSAEK once vision is affected enough to warrant surgery, with waiting times for first cornea clinic typically running into many months and an additional wait for theatre. There is no NHS option for combined cataract surgery with same-session DSO except in specific tertiary centres.
The private route lets you choose a cornea surgeon with a high DSO case-load, have a full corneal imaging workup at the first visit, and book surgery within a few weeks. Combined DSO + cataract surgery with a chosen IOL (including premium lenses) is straightforward to schedule, and follow-up is consultant-led throughout.
Insurance and funding
UK private medical insurers usually fund DSO when it is clinically indicated for Fuchs dystrophy, billed against an appropriate CCSD code for corneal endothelial surgery, with pre-authorisation in advance. If you choose to combine DSO with cataract surgery and a premium intraocular lens upgrade, expect the insurer to fund the medically necessary surgery and for the premium lens upgrade fee to be self-pay. Refractive lens exchange in eyes without a cataract is not insurer-funded. The clinic can usually liaise directly with major insurers (Bupa, AXA, Aviva, Vitality, WPA) once a consultant has confirmed indication.
For self-pay patients, transparent fixed quotes and finance options are available; see our finance page and insured patients page for full details.
Risks and limitations of DSO
- Non-clearance: in roughly 15-25% of selected patients the cornea does not clear and a DMEK is needed; this is the principal limitation of DSO.
- Slow visual recovery: clearance can take 4-12 weeks, occasionally longer; vision is hazy in that interval.
- Persistent stromal oedema: very rarely the cornea remains chronically oedematous and pain or recurrent erosions develop, mandating graft surgery.
- Steroid response: ROCK inhibitors are well tolerated but conjunctival hyperaemia and (rarely) cystic epithelial changes can occur.
- Cystoid macular oedema: a small risk after any intraocular procedure, particularly in combined DSO + cataract surgery; usually responds to topical anti-inflammatories.
- IOP changes: transient post-operative pressure rises are managed with eye drops.
- Endophthalmitis: a small (around 1 in 1,000-2,000) risk shared with any intraocular surgery.
Your surgeon will go through these and any individual factors in your case at consent, and you will be given a written, named contact for urgent post-operative concerns.
Recovery timeline after DSO
First 24-72 hours
Mild gritty sensation and light sensitivity; vision is blurred. Topical antibiotic, frequent steroid and ROCK inhibitor drops. Day-1 check at the clinic.
Weeks 1-4
Corneal epithelium heals, oedema gradually improves; you may see fluctuating vision. Most patients return to office work after 1-2 weeks.
Weeks 4-12
Central clearance progresses as peripheral cells migrate inwards; pachymetry falls. Driving usually resumed once acuity meets DVLA standard.
3-6 months
Final cornea thickness and refractive endpoint reached; new spectacles prescribed if needed. ROCK inhibitor weaned.
How to choose a UK DSO clinic
- Consultant cornea fellowship: the surgeon should have completed a cornea and external eye disease fellowship and perform DMEK/DSAEK as well as DSO.
- Documented DSO case-load: ask how many DSO procedures they have performed and their clearance rate.
- Specular microscopy and AS-OCT: the clinic must be able to image the endothelium quantitatively to select cases.
- Rescue DMEK on-site: the same surgeon and clinic should be able to perform DMEK if DSO fails.
- CQC registration: day-case theatres should be CQC-registered with a full ophthalmic anaesthetic capability.
- Written package and rescue pricing: a transparent, fixed quote that includes a defined follow-up window and a rescue DMEK fee.
If you would like a second opinion on your suitability for DSO before committing, our consultants offer a free online review with corneal imaging interpretation.
DSO frequently asked questions
How is DSO different from a corneal transplant?
DSO removes only the diseased central layer of your own cornea and relies on your healthy peripheral endothelial cells to migrate inwards. No donor tissue is used. DMEK and DSAEK transplants replace the diseased layer with thin donor tissue from a corneal donor.
Why might my surgeon recommend DSO over DMEK?
In selected mild-to-moderate Fuchs with a healthy peripheral endothelium, DSO offers comparable final vision without donor tissue, with a lower long-term steroid burden and zero graft-rejection risk. It preserves the option to have DMEK later if needed.
How long until I can see clearly after DSO?
Most patients notice gradual improvement over 4-12 weeks as the central cornea clears. A few clear in days, while others take longer; ROCK inhibitor drops often accelerate clearance.
What happens if DSO does not work?
In approximately 15-25% of selected eyes the cornea fails to clear. The straightforward backup is a DMEK transplant, which can be performed without any compromise to the eye or the final visual result.
Does DSO hurt?
The procedure is performed under topical anaesthetic drops; most patients feel pressure and light rather than pain. There is a gritty, watery sensation for a day or two afterwards.
Can DSO be combined with cataract surgery?
Yes, frequently. Combined DSO + phacoemulsification cataract surgery with an intraocular lens is well established and means one operation, one recovery, and a single set of post-operative visits.
Do I need ROCK inhibitor drops?
Many DSO programmes use a course of netarsudil or ripasudil off-licence after surgery to encourage endothelial cell migration. The evidence base is growing and most series show shorter time to clearance.
Will I need steroid drops for life?
No. Because no donor tissue is implanted, there is no graft to reject, and steroid drops can usually be stopped after a few months. This is one of the key advantages over DMEK and DSAEK.
How do you decide if my peripheral endothelium is healthy enough?
A specular microscope photographs the endothelial cell layer and counts cell density (cells/mm²) in the periphery. Combined with corneal thickness mapping and slit-lamp grading of guttae, this guides whether DSO is likely to clear your cornea.
Can DSO be done if I already have a corneal graft?
Usually not. A failed graft or significant stromal scarring is better managed with a fresh DMEK or DSAEK. DSO is generally a first-line option for native Fuchs dystrophy.
Is DSO available on the NHS?
A small number of NHS tertiary cornea centres offer DSO, but availability and waiting times vary. Most NHS Fuchs pathways still default to DMEK/DSAEK. Private DSO offers prompt access and choice of surgeon.
Will my insurance pay for DSO?
Most major UK insurers fund DSO when it is clinically indicated for Fuchs dystrophy, with pre-authorisation. Any premium IOL upgrade in a combined cataract + DSO procedure is normally self-pay.
How urgent is treatment if I have Fuchs dystrophy?
Fuchs is usually slowly progressive over years. Surgery is offered when symptoms (morning blur, glare, declining vision) interfere with daily life. DSO works best when performed before the disease becomes advanced, while peripheral endothelial reserve is still good.
Methodology and sources
UK 2026 self-pay pricing on this page reflects published private fees from CQC-registered ophthalmic providers and consultant cornea services at the time of last review (May 2026), expressed as typical per-eye ranges rather than fixed prices. Clinical content has been written by the Eye Surgery Clinic editorial team, reviewed by a UK GMC-registered consultant ophthalmologist with cornea fellowship training. Evidence is drawn from peer-reviewed cornea literature on Descemet stripping only and rho-kinase inhibitor adjunct therapy (Moshirfar, Garcerant, Borkar, Colby and others), Royal College of Ophthalmologists professional guidance, and the EBAA/Cornea Society guidance on lamellar endothelial keratoplasty. Page last reviewed 23 May 2026 against the live URL set on eyesurgeryclinic.co.uk.
Book a consultant cornea assessment
Find out whether DSO is right for your Fuchs dystrophy with a same-week consultant cornea appointment, complete with corneal imaging, specular microscopy and a transparent UK 2026 quote.
Or call 0800 852 7782.
Back to Treatments